Teladoc Health Chief Legal Officer Resigns; Successor Appointed

What Happened

• Teladoc Health, Inc. filed an 8-K on September 25, 2026, announcing that Chief Legal Officer and Secretary Adam C. Vandervoort informed the company he will resign effective November 1, 2026.
• Jonathan Dorfman, currently Senior Vice President, Securities & Corporate Law, will assume the roles of Chief Legal Officer and Secretary upon Mr. Vandervoort’s departure.

Key Details

• Resignation notice date: September 24, 2026; 8-K filed September 25, 2026.
• Effective resignation date: November 1, 2026.
• Mr. Vandervoort stated his resignation was made “with good reason” under his executive severance agreement.
• Transition support: Mr. Vandervoort will provide unpaid advisory services (no compensation) to assist the handover through November 1, 2027.

Why It Matters

• Leadership continuity: Naming an internal successor (Jonathan Dorfman) signals a planned, internal transition of legal and corporate governance responsibilities, which can reduce disruption.
• Potential compensation/severance implications: The filing notes “with good reason” under the executive severance agreement, which may relate to contractual severance rights, but the 8-K does not disclose any payment amounts or terms.
• For investors, the change affects the company’s legal leadership and may be relevant for governance oversight, regulatory matters, and ongoing legal work; the company has provided a one-year advisory overlap to support a smooth transition.